echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Gut microbes predict survival in advanced non-small cell lung cancer, study finds

    Gut microbes predict survival in advanced non-small cell lung cancer, study finds

    • Last Update: 2022-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The development of immune checkpoint inhibitors (ICIs) targeting the PD-1-PD-L1 interaction has transformed the treatment landscape for patients with advanced NSCLC1


    It has been shown that the composition of the gut microbiota has biological significance in influencing peripheral immune tension and the effectiveness of ICIs in cancer patients, and that the gut microbiota may contribute to the immunostimulatory mode of action of ICIs16


    Recently, a research paper titled "Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer" published in Nat Med found that Akk could predict 12 Monthly Survival Rate!

    In the present study, we prospectively validated the predictive value of fecal Akk using metagenomics-based microbiome analysis in 338 patients with advanced NSCLC treated with first- or second-line ICIs


    Akk in feces is associated with clinical benefit of ICI

    This study proposes that the relative abundance of Akk can serve as a reliable biomarker for the prognosis of PD-1-blocking immunotherapy patients


    Note: The original text has been deleted

    Reference: Derosa, L.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.